These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 20870974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL.
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL.
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT.
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [Abstract] [Full Text] [Related]

  • 8. Short term changes a surprise with smokeless tobacco. Oral lesions.
    Grady D, Greene J, Ernster VL, Daniels TE, Stillman L, Silverman S.
    J Am Dent Assoc; 1991 Jan; 122(1):62-4. PubMed ID: 1999587
    [No Abstract] [Full Text] [Related]

  • 9. Experts fear Swedish snus sales in the U.S. could thwart anti-tobacco measures.
    Savage L.
    J Natl Cancer Inst; 2007 Sep 19; 99(18):1358-9, 1365. PubMed ID: 17848661
    [No Abstract] [Full Text] [Related]

  • 10. Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami DK, Lemmonds C, Tomar SL.
    Prev Med; 2004 Mar 19; 38(3):309-17. PubMed ID: 14766113
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV, Heavner KK.
    Biomarkers; 2009 Jul 19; 14 Suppl 1():79-84. PubMed ID: 19604065
    [Abstract] [Full Text] [Related]

  • 13. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W, Gartner C.
    Public Health; 2009 Mar 19; 123(3):287-91. PubMed ID: 19223052
    [Abstract] [Full Text] [Related]

  • 14. Regulating E-cigarettes: a rule proposed by the FDA aims to extend authority to E-cigarettes, other tobacco products.
    Printz C.
    Cancer; 2014 Jul 15; 120(14):2069-71. PubMed ID: 24985247
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Smokeless tobacco use by youth: a health concern.
    Johnson GK, Squier CA.
    Pediatr Dent; 1993 Jul 15; 15(3):169-74. PubMed ID: 8378153
    [Abstract] [Full Text] [Related]

  • 19. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
    Gartner CE, Hall WD, Chapman S, Freeman B.
    PLoS Med; 2007 Jul 15; 4(7):e185. PubMed ID: 17608560
    [Abstract] [Full Text] [Related]

  • 20. The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort.
    Galanti MR, Rosendahl I, Wickholm S.
    Nicotine Tob Res; 2008 Feb 15; 10(2):315-23. PubMed ID: 18236296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.